<!DOCTYPE html>
<html class="">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>Pulmonary embolism - Approach | BMJ Best Practice</title>
      <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
      <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
      <meta name="description" content="Pulmonary embolism (PE) is a life-threatening condition resulting from dislodged thrombi occluding the pulmonary vasculature; right heart failure and cardiac arrest may ensue if not aggressively treated. Symptoms include chest pain, dyspnoea, and a sense of apprehension. Haemoptysis and syncope a...">
      <!-- Optimize Page Hiding Snippet --> 
      <!-- <style>.async-hide
         { opacity: 0 !important}
      </style>
      <script async="" src="../js/adrum-ext.0086dbec5e8a6e717bf36d3a06b62042.js"></script><script src="../js/414393182248444" async=""></script><script async="" src="../js/fbevents.js"></script><script type="text/javascript" async="" src="../js/analytics.js"></script><script async="" src="../js/get-loader.js"></script><script type="text/javascript" async="" src="../js/insight.min.js"></script><script type="text/javascript" async="" src="../js/js"></script><script type="text/javascript" async="" src="../js/uwt.js"></script><script type="text/javascript" async="" src="../js/4896.js"></script><script type="text/javascript" async="" src="../js/analytics.js"></script><script async="" src="../js/gtm.js"></script><script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date; h.end=i=function()
         {s.className=s.className.replace(RegExp(' ?'+y),'')}
         ; (a[n]=a[n]||[]).hide=h;setTimeout(function()
         
         {i();h.end=null}
         ,c);h.timeout=c;})(window,document.documentElement,'async-hide','dataLayer',3000,
         
         {'GTM-K3TZ3JV':true}
         );
      </script> -->
      <!-- end Optimize Page Hiding Snippet -->
      <!-- Google Tag Manager -->
      <!-- <script>
         /*<![CDATA[*/
         
          
         window.dataLayer = window.dataLayer || [];
         window.dataLayer.push({
                    'icsId': null,
                    'pi_icsId': "id82087",
                    'pi_icsName': "BMJ Group (Online access from BMA House)",
                    'access_rights': true,
                    'ics_groupings': [{"name":"Country Grouping"}],
                    'ics_countryName': "GB and ROW",
                    'siteLanguage': "en-gb",
                    'contentLanguage': "en-gb"
                 });
         		  
         /*]]>*/
            
      </script> -->
      <!-- <script>
         (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
         new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
         j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
         'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
         })(window,document,'script','dataLayer', 'GTM-K3TZ3JV');
      </script> -->
      <!-- End Google Tag Manager -->
      <!-- /* if user in China */ -->
      <link rel="stylesheet" type="text/css" media="screen" href="../css/material.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/styles.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/external.css">
      <link rel="shortcut icon" href="https://resources.bmj.com/repository/images/favicon.ico">
      <!-- <link rel="canonical" href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach">
      <link rel="alternate" hreflang="uk-ua" href="https://bestpractice.bmj.com/topics/uk-ua/116/diagnosis-approach">
      <link rel="alternate" hreflang="en-ie" href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach">
      <link rel="alternate" hreflang="az-az" href="https://bestpractice.bmj.com/topics/az-az/116/diagnosis-approach">
      <link rel="alternate" hreflang="en-us" href="https://bestpractice.bmj.com/topics/en-us/116/diagnosis-approach">
      <link rel="alternate" hreflang="ru" href="https://bestpractice.bmj.com/topics/ru-ru/116/diagnosis-approach">
      <link rel="alternate" hreflang="pt" href="https://bestpractice.bmj.com/topics/pt-br/116/diagnosis-approach">
      <link rel="alternate" hreflang="ka-ge" href="https://bestpractice.bmj.com/topics/ka-ge/116/diagnosis-approach">
      <link rel="alternate" hreflang="pt-br" href="https://bestpractice.bmj.com/topics/pt-br/116/diagnosis-approach">
      <link rel="alternate" hreflang="en" href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach">
      <link rel="alternate" hreflang="es-es" href="https://bestpractice.bmj.com/topics/es-es/116/diagnosis-approach">
      <link rel="alternate" hreflang="zh-cn" href="https://bestpractice.bmj.com/topics/zh-cn/116/diagnosis-approach">
      <link rel="alternate" hreflang="es" href="https://bestpractice.bmj.com/topics/es-es/116/diagnosis-approach">
      <link rel="alternate" hreflang="zh" href="https://bestpractice.bmj.com/topics/zh-cn/116/diagnosis-approach">
      <link rel="alternate" hreflang="x-default" href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach">
      <link rel="alternate" hreflang="ru-ru" href="https://bestpractice.bmj.com/topics/ru-ru/116/diagnosis-approach">
      <link rel="alternate" hreflang="vi" href="https://bestpractice.bmj.com/topics/vi-vn/116/diagnosis-approach">
      <link rel="alternate" hreflang="uk" href="https://bestpractice.bmj.com/topics/uk-ua/116/diagnosis-approach">
      <link rel="alternate" hreflang="ka" href="https://bestpractice.bmj.com/topics/ka-ge/116/diagnosis-approach">
      <link rel="alternate" hreflang="az" href="https://bestpractice.bmj.com/topics/az-az/116/diagnosis-approach">
      <link rel="alternate" hreflang="vi-vn" href="https://bestpractice.bmj.com/topics/vi-vn/116/diagnosis-approach">
      <link rel="alternate" hreflang="en-gb" href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach"> -->
      <!--[if lte IE 9]>
      <link rel="stylesheet" type="text/css" media="screen" href="/gzip_1791a8687c5480ce19e791d0825e7a6b/css/lte-ie-9.css" >
      <![endif]-->
      <!-- <script>
         /*<![CDATA[*/
           var appdynamics_app_key="AD-AAB-AAF-RGR";
         /*]]>*/
           	window["adrum-app-key"] = appdynamics_app_key;
           	window['adrum-start-time'] = new Date().getTime();
           
      </script>
      <script type="text/javascript" src="../js/appdynamics.js"></script>
      <script type="application/ld+json">
         [
         
         { "@context": "http://schema.org", "@type": "MedicalCondition" }
         ,{
         "isAccessibleForFree": "False",
         "hasPart":
         
         { "@type": "WebPageElement", "isAccessibleForFree": "False", "cssSelector" : ".gpw" }
         }]
      </script> -->
      
   </head>
   <body class="gpw">
      <div role="dialog" aria-live="polite" aria-label="cookieconsent" aria-describedby="cookieconsent:desc" class="cc-window cc-banner cc-type-info cc-theme-classic cc-bottom cc-color-override--38786966 cc-invisible" style="display: none;">
         <!--googleoff: all--><span id="cookieconsent:desc" class="cc-message">We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our 
         <a aria-label="learn more about cookies" role="button" tabindex="0" class="cc-link" href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">cookies policy</a></span>
         <div class="cc-compliance"><a aria-label="dismiss cookie message" role="button" tabindex="0" class="cc-btn cc-dismiss">OK!</a></div>
         <!--googleon: all-->
      </div>
      <!-- Google Tag Manager (noscript) -->
      <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K3TZ3JV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
      <!-- End Google Tag Manager (noscript) -->
      <!-- /* if user in China */ -->
      <header id="header" role="banner">
         <a class="sr-only" href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#sr-content">Skip to main content</a>
         <div class="bg-info text-white">
         </div>
         <nav id="globalNav" class="logo-img-mob navbar navbar-toggleable-md">
            <div class="container">
               <a href="https://bestpractice.bmj.com/" class="mobLogo"><span class="remove"><abbr>BMJ</abbr> Best Practice</span></a>
               <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
               <span class="material-icons"></span>
               </button>
               <div id="navbarNav" class="collapse navbar-collapse">
                  <ul id="globalNav-ul" class="navbar-nav" role="menubar">
                     <li id="globalNav-access" class="nav-item" role="presentation">
                        <span class="nav-link"> 
                        Access provided by: 
                        BMJ Group (Online access from BMA House)
                        </span>
                     </li>
                     <li id="globalNav-help" class="nav-item dropdown" role="menuitem">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#" id="navbarDropdownMenuLink02" class="nav-link dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> 
                        Help <span class="states">
                        <span class="material-icons"></span>
                        <span class="material-icons"></span>
                        </span>
                        </a>
                        <div id="globalNav-help-options" class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownMenuLink02">
                           <span class="material-icons"></span>
                           <ul role="menu">
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></li>
                           </ul>
                        </div>
                     </li>
                     <li id="globalNav-register" class="nav-item">
                        <a href="https://bestpractice.bmj.com/registration" class="nav-link">Create account</a>
                     </li>
                     <li id="globalNav-login" class="nav-item">
                        <a href="https://bestpractice.bmj.com/login" class="nav-link">Log in</a>
                     </li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
         <div id="mainSearch" class="container">
            <div class="row">
               <div class="col-lg-7">
                  <div class="logo-img"><a href="https://bestpractice.bmj.com/"><span class="remove"><abbr title="British Medical Journal">BMJ</abbr> Best Practice</span></a></div>
               </div>
               <div class="col-lg-5">
                  <style type="text/css">
                     #searchBoxWrap .tt-open:before {content: "Recently viewed topics:"; }
                     #searchBoxWrap .tt-label-override:before,
                     #searchBoxWrap .tt-suggested:before {content: "Suggested topics:" !important; }
                  </style>
                  <form id="searchBoxForm" action="https://bestpractice.bmj.com/search" role="search" novalidate="novalidate">
                     <div class="input-group">
                        <div id="searchBoxWrap">
                           <label for="q" class="sr-only">Search</label>
                           <span class="twitter-typeahead" style="position: relative; display: inline-block;">
                              <input id="q" type="text" name="q" placeholder="Search conditions, symptoms..." value="" class="tt-input" autocomplete="off" spellcheck="false" dir="auto" style="position: relative; vertical-align: top;">
                              <pre aria-hidden="true" style="position: absolute; visibility: hidden; white-space: pre; font-family: sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; word-spacing: 0px; letter-spacing: 0px; text-indent: 0px; text-rendering: auto; text-transform: none;"></pre>
                              <div class="tt-menu" style="position: absolute; top: 100%; left: 0px; z-index: 100; display: none;">
                                 <div class="tt-dataset tt-dataset-0"></div>
                              </div>
                           </span>
                           <button id="mainSearchBtn" type="submit"><span class="material-icons"></span></button>
                        </div>
                     </div>
                  </form>
                  <script>
                     /*<![CDATA[*/
                     
                            // These are required in completion, see BP-232
                            var searchDefaultLanguageCode = "en-gb";
                            var regionName = "GB and ROW";
                            var regionAvailableLanguagesCodes = [{"id":"1","code":"en-gb","displayName":"English"},{"id":"3","code":"pt-br","displayName":"Portugu\u00EAs"},{"id":"5","code":"es-es","displayName":"Espa\u00F1ol"},{"id":"7","code":"ru-ru","displayName":"\u0420\u0443\u0441\u0441\u043A\u0438\u0439"}];
                            var availableLanguages = [];
                     
                            for (i = 0; i < regionAvailableLanguagesCodes.length; i++) {
                                availableLanguages.push(regionAvailableLanguagesCodes[i].code);
                            }
                     /*]]>*/
                  </script>
               </div>
            </div>
         </div>
         <nav id="mainNav" class="navbar navbar-toggleable-md" role="navigation">
            <div class="container">
               <div id="mainNavbarNav">
                  <ul class="navbar-nav" role="menubar">
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
      </header>
      <script type="text/javascript" id="">(function(){var f=google_tag_manager["GTM-K3TZ3JV"].macro(4),b=google_tag_manager["GTM-K3TZ3JV"].macro(5),a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};f?"true"!=b&&("justLoggedIn"==b?a("loggedIn","true",2):a("loggedIn","justLoggedIn",2)):a("loggedIn","false",2)})();</script>
      <main id="tmp" class="container tmp tmp-basic main-container" role="main">
         <script type="text/javascript">
            /*<![CDATA[*/ 
            var topicId = 116; 
            var langCode="en-gb"; 
            /*]]>*/
         </script>
         <div id="topicNav" class="container">
            <div class="lang">
               <ul role="menu">
                  <li><a href="https://bestpractice.bmj.com/topics/en-gb/116" class="active">English</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/pt-br/116">Português</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/es-es/116">Español</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/ru-ru/116">Русский</a></li>
               </ul>
            </div>
            <div id="topicMenuTopBg" style="height: 110px;"></div>
            <div id="topicMenuTopWrap" style="height: 110px;">
               <div id="topicMenuTop" style="height: 110px;">
                  <h1>Pulmonary embolism</h1>
                  <div class="pdf-links-nav">
                     <div class="pdf">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/pdf/116.pdf" target="_blank">
                        <span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span>
                        </a>
                     </div>
                  </div>
                  <div id="mobileMenu" class="mUp">
                     <a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#" role="button">
                     <span><span class="material-icons"></span> Menu</span>
                     <span><span class="material-icons"></span> Close</span>
                     </a>
                  </div>
                  <ul id="menuLinks" role="menu">
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#smenu-0" aria-owns="menu-0">Overview <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#smenu-1" aria-owns="menu-1">Theory <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#smenu-2" aria-owns="menu-2">Diagnosis <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#smenu-3" aria-owns="menu-3">Management <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#smenu-4" aria-owns="menu-4">Follow up <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#smenu-5" aria-owns="menu-5">Resources <span class="material-icons"></span><span class="material-icons"></span></a></li>
                  </ul>
               </div>
            </div>
            <div id="topicMenuBottomWrap" style="height: 176px;">
               <nav id="topicMenuBottom" class="mUp" role="navigation" style="height: 176px;">
                  <ul id="menus" role="menubar">
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Overview</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-0">
                           <li><a href="116_overview_summary.html" id="Summary">Summary</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Theory</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-1">
                           <li><a href="116_theory_epidemiology.html" id="Epidemiology">Epidemiology</a></li>
                           <li><a href="116_theory_aetiology.html" id="Aetiology">Aetiology</a></li>
                           <li><a href="116_theory_case_history.html" id="Case history">Case history</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Diagnosis</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-2">
                           <li><a href="116_diagnosis_recommendations.html" id="Approach" class="active">Recommendations</a></li>
                           <li><a href="116_diagnosis_history-exam.html" id="History and exam">History and exam</a></li>
                           <li><a href="116_diagnosis_investigations.html" id="Investigations">Investigations</a></li>
                           <li><a href="116_diagnosis_differentials.html" id="Differentials">Differentials</a></li>
                           <li><a href="116_diagnosis_criteria.html" id="Criteria">Criteria</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Management</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-3">
                           <li><a href="116_management_recommendations.html" id="Approach">Recommendations</a></li>
                           <li><a href="116_management_treatment_algorithm.html" id="Treatment algorithm">Treatment algorithm</a></li>
                           <li><a href="116_management_emerging.html" id="Emerging">Emerging</a></li>
                           <li><a href="116_management_prevention.html" id="Prevention">Prevention</a></li>
                           <li><a href="116_management_patient_discussions.html" id="Patient discussions">Patient discussions</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Follow up</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-4">
                           <li><a href="116_follow_up_monitoring.html" id="Monitoring">Monitoring</a></li>
                           <li><a href="116_follow_up_complications.html" id="Complications">Complications</a></li>
                           <li><a href="116_follow_up_prognosis.html" id="Prognosis">Prognosis</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Resources</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-5">
                           <li><a href="116_resources_guidelines.html" id="Guidelines">Guidelines</a></li>
                           <li><a href="116_resources_images_videos.html" id="Images and videos">Images and videos</a></li>
                           <li><a href="116_resources_references.html" id="References">References</a></li>
                           <li><a href="116_resources_patient_leaflets.html" id="Patient leaflets">Patient leaflets</a></li>
                           <li><a href="116_resources_evidence.html" id="Evidence">Evidence</a></li>
                        </ul>
                     </li>
                     <li class="mpdf"><a href="https://bestpractice.bmj.com/topics/en-gb/116/pdf/116.pdf" target="_blank"><span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span></a></li>
                  </ul>
               </nav>
            </div>
         </div>
         <h2 id="sr-content">Recommendations</h2>
         <div id="poce_contents" class="invest">
            <div class="card p-3 mb-4">
               <div class="card-block poce_urgent">
                  <section>
                     <h3>Urgent considerations</h3>
                     <ul>
                        <li><strong>Assess for signs of shock or hypotension (ABCDE approach) as this can indicate a massive/central PE with high risk of a poor outcome. </strong>
                        <ul>
                        <li><strong>Seek senior support and escalate to critical care</strong> if a high-risk PE is suspected. <strong>[ESC][ACP]</strong></li>
                        <li><strong>A high-risk PE is defined as a systolic blood pressure (SBP) &lt;90 mmHg or an SBP drop &ge; 40 mmHg for &gt;15 minutes,</strong> if not caused by a new-onset arrhythmia, hypovolaemia, or sepsis. [ESC]</li>
                        <li><strong>Other signs of shock include </strong>altered cognition, cool extremities, mottled or ashen skin, slow capillary refill, clamminess, and oliguria.</li>
                        <li><strong>If the patient is in peri-arrest/cardiac arrest and PE is suspected it is common practice to give thrombolysis </strong>without waiting for results of investigations, based on discussion between senior clinicians.</li>
                        <li><strong>Ensure early respiratory support. Titrate oxygen to 94% to 98% (or 88% to 92% for patients at risk of hypercapnic failure). [ESC]</strong></li>
                        <li><strong>Give intravenous fluids if SBP &lt; 90 mmHg or there are other signs of shock</strong> but monitor for signs of heart failure. <strong>[ESC]</strong></li>
                        </ul>
                        </li>
                        <li><strong>In a patient with shock or hypotension, urgently confirm or rule out a PE using either computed tomographic pulmonary angiography (CTPA) or echocardiography </strong>(if CTPA is unavailable or the patient&rsquo;s condition is so critical that only bedside investigations are possible). [ESC]
                        <ul>
                        <li>If PE is confirmed on CTPA or signs of right ventricular (RV) overload are seen on echocardiography, <strong>arrange urgent primary reperfusion</strong>, usually with <strong>thrombolysis</strong>.</li>
                        </ul>
                        </li>
                        </ul>
                  </section>
               </div>
            </div>

            <h2>Key points</h2>
               <div class="card p-3 mb-4">
                     <div class="row">
                        <div class="col-md-12">
                           <h3>Presentation</h3>
                           <ul>
                              <li><strong>Suspect pulmonary embolism (PE) in a patient with acute onset of dyspnoea, pleuritic chest pain, or features of deep vein thrombosis (DVT).</strong>
                              <ul>
                              <li>At least one of these features is present in 97% of people with PE.[MISS]</li>
                              <li>Symptoms typically come on suddenly rather than gradually.</li>
                              <li><strong>Dyspnoea is the most common presenting feature</strong> and may be acute and severe in a central PE but is often mild and transient in a small, peripheral PE.</li>
                              </ul>
                              </li>
                              <li>Around 95% of patients with PE are haemodynamically stable on presentation.
                                 <ul>
                              <li>The 5% of patients who have a <strong>high-risk (haemodynamically unstable) PE</strong> may also have features of <strong>hypotension, shock, or tachycardia</strong> and can be hypoxaemic at rest.</li>
                              </ul></li>
                              
                              <li>A patient with a PE may also present with <strong>cough </strong>or, more rarely, with<strong> fever or haemoptysis</strong>. [ESC]</li>
                              <li>Strong risk factors include pregnancy/6 weeks postpartum; active cancer; recent surgery or immobilisation; and a history of DVT. [ESC]</li>
                           </ul>
                                 
                            <br/>
                           <h3>Assessing the clinical probability of PE</h3>
                           <ul>
                              <li><strong>Use the Wells (or Geneva) score to assess the likelihood of a PE in any patient who is haemodynamically stable. </strong>This will categorise the patient into either &lsquo;PE likely&rsquo; (Wells score &gt;4) or 'PE unlikely' (Wells score &le;4).[ESC] [NICE] </li>
                              <li><strong>PE can be ruled out in around 30% of patients </strong>who present to the emergency department with a suspected PE through a <strong>combination of clinical probability assessment using the Wells (or Geneva) score, plus D-dimer testing if indicated.</strong> [ESC]</li>
                              <li>If a patient has a &lsquo;<strong>PE likely</strong>&rsquo; Wells (or Geneva) score, <strong>start anticoagulation</strong> then arrange investigation with definitive imaging (computed tomographic pulmonary angiography [CTPA] if available).</li>
                              <li>If a patient has a <strong>'PE unlikely' </strong>Wells (or Geneva) score, <strong>order a D-dimer unless the patient fulfils all the Pulmonary Embolism Rule-Out Criteria</strong> (in which case a PE can be effectively ruled out and no further investigations are indicated). [NICE] [ESC] [ACP]</li>
                              <li>If <strong>D-dimer level is elevated</strong>, start anticoagulation and arrange CTPA to confirm or exclude a PE. A normal D-dimer level safely excludes a PE in a patient who had a 'PE unlikely' Wells (or Geneva) pre-test score.</li>
                              <li>Other differentials to consider include <strong>respiratory, cardiac, and musculoskeletal causes</strong> <strong>as well as gastro-oesophageal reflux disease and pregnancy</strong>. Other<strong> causes of syncope or pre-syncope</strong> should also be examined including vasovagal syncope, orthostatic (postural) hypotension, cardiac arrhythmias, seizures, and cerebrovascular disorders. [ESC]</li>
                           </ul>
                           
                           <br/>
                           <h3>Diagnostic confirmation</h3>
                           <ul>
                              <li><strong>Confirm diagnosis in most </strong><strong>patients</strong><strong> using CTPA, </strong>which will show direct visualisation of a thrombus in a pulmonary artery and appears as a partial or complete intraluminal filling defect. [ESC] [NICE][ACP]</li>
                              <li><strong>Avoid CTPA radiation in patients with a suspected concurrent DVT</strong> by using lower limb compression venous ultrasound. [NICE] [ACP]</li>
                              <li><strong>A </strong><strong>ventilation-perfusion (V/Q)</strong><strong> scan may be preferred to CTPA to minimise radiation exposure in certain patient groups</strong>. This is a radiation- and contrast medium-sparing procedure and should be used in patients with contraindications or relative contraindications to CT (e.g., contrast allergy, moderate to severe renal failure, pregnancy, young patients).[ESC] [NICE]</li>
                           </ul>
                           <br/>
                           <h3>Suspected PE in pregnancy</h3>
                           <ul>
                              <li><strong>PE is the leading cause of maternal mortality in developed countries</strong>. There is a <strong>fourfold increased risk of venous thromboembolism (VTE) </strong>throughout pregnancy compared with non-pregnant women. This risk rises sharply in the postnatal period and is <strong>up to 60 times higher in the 3 months after delivery</strong>, compared with the risk in non-pregnant women. [ESC] [TOWER]</li>
                              <li><strong>Symptoms and signs of PE may be less specific in pregnant women</strong>. [ACP] Be cautious in interpreting breathlessness as it is a common symptom in pregnancy. [ESC]</li>
                              <li><strong>Investigation of PE in pregnancy should aim to minimise exposure to radiation-associated imaging wherever possible. [ESC]</strong></li>
                           </ul>
                        </div>
                     </div>
               </div>

            <div id="diagrecs">
               <h2>Full recommendations</h2>
                  <div class="row">
                     
                     <div class="col-md-9">
                        
                        <p>Click below to see a full list of recommendations</p>
                     </div>
                     <div class="col-md-3 text-right">
                        <h3><a href="https://bestpractice.bmj.com/topics/en-gb/116/investigations#">
                           <span class="hidden-sm-down">
                           <span class="msg">VIEW ALL</span>
                           <span class="material-icons" role="button"><span></span><span></span></span>
                           </span>
                           </a>
                        </h3>
                     </div>
                  </div>
                  <div class="card">
                     <div class="card-block">
                        <div class="container">
                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                              <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-asdasdsad11">
                                 <h3>Clinical presentation</h3>
                              </div>
                           </div>
                           <div id="collapseTest-18f09885-71b3-436a-b52e-asdasdsad11" class="row rowDetails p-3 collapse">
                              <p><strong>Symptoms of PE typically have an acute rather than a gradual onset [ESC].</strong></p>
                              <p><strong>Patients typically present with at least one of dyspnoea, pleuritic chest pain, or features of deep vein thrombosis (DVT). [ESC] [NICE]</strong></p>
                              <ul>
                              <li><strong>Dyspnoea</strong>
                              <ul>
                              <li>The<strong>most common presenting feature</strong> -<strong> it is present in 50% of patients</strong>who are subsequently found to have a PE. [ESC]</li>
                              <li>Dyspnoea may be <strong>acute and severe in a central PE</strong> but is often <strong>mild and may be transient in a small peripheral PE</strong>. [ESC]</li>
                              <li>Tachypnoea (respiratory rate &ge;20 breaths per minute) is a common presenting sign in patients with acute PE (21%-39%). [POLLACK]</li>
                              </ul>
                              </li>
                              </ul>

                              <div id="tip_pitfall" class="card card-inverse mb-4">
                                 <div class="card-block">
                                 <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                 <p class="card-text"><strong>In a patient with pre-existing heart failure or lung disease, worsening dyspnoea may be the only presenting symptom of a PE.[ESC]</strong></p>
                                 </div>
                                 </div>
                                 <p><strong>Pleuritic chest pain</strong></p>

                                 <ul>
                                 <li><strong>Seen at presentation in 39% of patients</strong>subsequently diagnosed with a PE. [ESC]</li>
                                 <li>The pain is <strong>normally localised to one side of the chest</strong> and is unlikely to be central. This is usually caused by pleural irritation due to distal emboli causing pulmonary infarction. [STEIN]</li>
                                 <li><strong>Central PE may also present with angina-like chest pain but this is uncommon. This may reflect right ventricular (RV) ischaemia and requires differential diagnosis with acute coronary syndrome (ACS) or aortic dissection. [ESC]</strong></li>
                                 </ul>

                              <div id="tip_pitfall" class="card card-inverse mb-4">
                                 <div class="card-block">
                                 <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                 <p class="card-text"><strong>Recurrent or transient episodes of pleuritic chest pain lasting minutes are very unlikely to be caused by multiple PEs.</strong></p>
                                 </div>
                                 </div>

                              <ul>
                                 <li><strong>Features of suspected DVT</strong>
                                 <ul>
                                 <li>Typically <strong>unilateral leg pain and swelling</strong>, although both legs may be affected.[NICEDVT]</li>
                                 <li><strong>Seen at presentation in 24% of patients</strong> subsequently diagnosed with a PE. [ESC]</li>
                                 </ul>
                                 </li>
                                 </ul>
                              
                              <p><strong>Cough and hypoxaemia are also common.</strong></p>
                                 <ul>
                                 <li><strong>Cough</strong>
                                 <ul>
                                 <li><strong>Seen at presentation in 23% of patients</strong>subsequently diagnosed with a PE. [ESC]</li>
                                 </ul>
                                 </li>
                                 <li><strong>Hypoxaemia</strong>
                                 <ul>
                                 <li>Hypoxaemia at rest may be suggestive of a massive PE whereas hypoxaemia solely on exertion is more often associated with a smaller PE.</li>
                                 </ul>
                                 </li>
                                 </ul>

                              <div id="tip_pitfall" class="card card-inverse mb-4">
                                 <div class="card-block">
                                 <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                 <p class="card-text"><strong>A normal oxygen saturation does not exclude PE.</strong></p>
                                 <ul>
                                 <li>Up to 40% of patients have normal arterial oxygen saturation and 20% have a normal alveolar-arterial oxygen gradient. [ESC]</li>
                                 </ul>
                                 </div>
                                 </div>

                              <p><strong>Patients with a massive/central PE, or those with a smaller PE but who have significant pre-existing cardiorespiratory impairment, typically present with:</strong></p>
                                 <ul>
                                 <li><strong>Syncope or pre-syncope</strong>
                                 <ul>
                                 <li>Seen at presentation in 6% of patients with PE. [ESC]</li>
                                 </ul>
                                 </li>
                                 <li><strong>Hypotension</strong>
                                 <ul>
                                 <li>Defined as systolic blood pressure &lt;90 mmHg. [ESC][NICECKS]</li>
                                 </ul>
                                 </li>
                                 </ul>
                                 <ul>
                                 <li><strong>Other features of shock</strong> [ESC]
                                 <ul>
                                 <li>Look for signs of altered cognition. Agitation and distress characterise early and milder stages, whereas unresponsiveness indicates more severe and advanced shock.</li>
                                 <li>Check for cool extremities, mottled or ashen skin, slow capillary refill, clamminess, and oliguria.</li>
                                 </ul>
                                 </li>
                                 <li><strong>Tachycardia</strong>
                                 <ul>
                                 <li>Heart rate &gt;100 bpm.</li>
                                 <li>Tachycardia is an important sign of a possible high-risk PE even in the absence of other signs of shock.</li>
                                 </ul>
                                 </li>
                                 </ul>

                              <p><strong>Rarer features of PE:</strong></p>
                                 <ul>
                                 <li><strong>Fever</strong>
                                 <ul>
                                 <li>Temperature &gt;37.8&deg;C. [BELL]</li>
                                 <li>Present in 10% of patients with PE. [ESC]</li>
                                 </ul>
                                 </li>
                                 <li><strong>Haemoptysis</strong>
                                 <ul>
                                 <li>Present in 8% of patients with PE. [ESC]</li>
                                 <li>It is commonly estimated that around half of patients presenting with apparent haemoptysis do not have true haemoptysis. Instead this could be epistaxis or blood from the gastrointestinal tract, upper airways, or gingiva. It is vital to take a clear and thorough history and examination to distinguish this.</li>
                                 </ul>
                                 </li>
                                 </ul>

                              <div id="tip_pitfall" class="card card-inverse mb-4">
                                 <div class="card-block">
                                 <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                 <p class="card-text"><strong>A PE is unlikely to be the cause in a patient who has an episode of syncope or pre-syncope but subsequently has normal observations, is haemodynamically stable and has no abnormality suggestive of a PE on their ECG.</strong></p>
                                 </div>
                                 </div>

                                 <div class="table-responsive">
                                    <p><strong>Summary: Frequency of presenting symptoms and signs in PE [ESC]</strong></p>
                                    <table class="alt-table">
                                       <thead>
                                          <th scope="col">Clinical feature</th>
                                          <th scope="col">% of patients with subsequently confirmed PE who had the clinical feature at presentation </th>
                                       </thead>
                                       <tbody>
                                          <tr>
                                             <td>Dyspnoea</td>
                                             <td>50%</td>
                                          </tr>
                                          <tr>
                                             <td>Pleuritic chest pain</td>
                                             <td>39%</td>
                                          </tr>
                                          <tr>
                                             <td>Signs of DVT (unilateral leg swelling)</td>
                                             <td>24%</td>
                                          </tr>
                                             <tr>
                                                <td>Cough</td>
                                                <td>23%</td>
                                             </tr>
                                             <tr>
                                                <td>Substernal chest pain </td>
                                                <td>15%</td>
                                             </tr>
                                             <tr>
                                                <td>Fever</td>
                                                <td>10%</td>
                                             </tr>
                                             <tr>
                                                <td>Haemoptysis</td>
                                                <td>8%</td>
                                             </tr>
                                             <tr>
                                                <td>Unilateral leg pain</td>
                                                <td>6%</td>
                                             </tr>
                                       </tbody>
                                    </table>
                                 </div>


                           </div>
                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                              <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-1245852">
                                 <h3>History</h3>
                              </div>
                           </div>
                           <div id="collapseTest-18f09885-71b3-436a-b52e-1245852" class="row rowDetails p-3 collapse">
                              <p><b>Your history should check for the following risk factors to help assess the likelihood of PE and to determine whether any subsequently confirmed PE is provoked or unprovoked: [ESC][NICE][] [POMP] [CROLES] [ORTEL]</b></p>
                              <ul>
                              <li>No provoking cause can be found in 30% of patients. [ESC]</li>
                              </ul>

                              <div id="allrfs" class="table-responsive">
                                    <table  class="table table-striped mt-3">
                                      <thead>
                                        <tr>
                                          <th scope="col" width="20%">Past medical history</th>
                                          <th scope="col" width="80%">Strong risk factors</th>
                                        </tr>
                                      </thead>
                                      <tbody>
                                        <tr>
                                          <th scope="row"></th>
                                          <td>
                                                <p><strong>Active cancer</strong></p>
                                                <ul>
                                                <li><strong>The highest relative risk of PE is in patients with multiple myeloma, brain and pancreatic cancer.</strong></li>
                                                <li>The largest numbers of episodes of PE are in patients with lung, colon, and prostate cancer. [FREYZEK]</li>
                                                <li>Active cancer is present in 22% of patients with confirmed PE. [GOLD]</li>
                                                </ul>
                                                <p><strong>Recent surgery or hospitalisation (last 3 months)</strong></p>
                                                <ul>
                                                <li>Present in 29% of patients with confirmed PE. [GOLD]</li>
                                                <li>Lower limb fractures and joint replacements are strong provoking factors for PE. [ESC]</li>
                                                </ul>
                                                <p><strong>Previous or current DVT</strong></p>
                                                <ul>
                                                <li>Present in 25% of patients with confirmed PE. [GOLD]</li>
                                                </ul>
                                                <p><strong>Pregnancy and 6 weeks postpartum </strong>[ESC][TOWER][POMP]</p>
                                                <ul>
                                                <li>There is a more than fourfold increased risk of thrombosis throughout pregnancy.</li>
                                                <li>The increased risk of PE is even higher in the postnatal period - up to 60 times higher in the 3 months after delivery, compared with the risk in non-pregnant women.</li>
                                                </ul>
                                          </td>
                                        </tr>
                                      </tbody>
                                    </table>
                                    <table class="table table-striped" style="margin-top: -16px;">
                                          <thead>
                                            <tr>
                                              <th scope="col" width="20%" style="background-color: #f5f5f5;"> </th>
                                              <th scope="col" width="80%">Weak risk factors</th>
                                            </tr>
                                          </thead>
                                          <tbody>
                                            <tr>
                                              <th scope="row" style="border-top: none;"></th>
                                              <td>
                                                   <p><strong>Other significant medical comorbidities</strong></p>
                                                   <ul>
                                                   <li>For example, congestive heart failure, COPD, concurrent sepsis. [GOLD]</li>
                                                   </ul>
                                                   <p><strong>Obesity</strong></p>
                                                   <ul>
                                                   <li>BMI &ge;29 kg/m2</li>
                                                   </ul>
                                                   <p><strong>Increasing age</strong></p>
                                                   <p><strong>Varicose veins</strong></p>
                                                   <p><strong>Known thrombophilias</strong></p>
                                                   <ul>
                                                   <li>Factor V Leiden mutation; prothrombin G20210A mutation; antithrombin deficiency; protein C deficiency; protein S deficiency; antiphospholipid antibody syndrome. [CROLES] [ORTEL]</li>
                                                   </ul>
                                                   <p><strong>Other</strong></p>
                                                   <ul>
                                                   <li>Central vein catheter</li>
                                                   <li>Nephrotic syndrome</li>
                                                   <li>Chronic dialysis</li>
                                                   <li>Myeloproliferative disorders</li>
                                                   <li>Paroxysmal nocturnal haemoglobinuria</li>
                                                   <li>Behcet's disease</li>
                                                   <li>Blood transfusion</li>
                                                   </ul>
                                              </td>
                                            </tr>
                                          </tbody>
                                    </table>
                                    <table class="table table-striped" style="margin-top: -16px;">
                                          <thead>
                                            <tr>
                                                <th scope="col" width="20%">Social history</th>
                                                <th scope="col" width="80%">Strong risk factors</th>
                                            </tr>
                                          </thead>
                                          <tbody>
                                            <tr>
                                              <th scope="row" style="border-top: none;"></th>
                                              <td>
                                                   <p><strong>History of immobilisation</strong></p>
                                                      <ul>
                                                      <li>&gt;5 days of bed rest present in 28% of patients with confirmed PE. [GOLD]</li>
                                                      </ul>
                                              </td>
                                            </tr>
                                          </tbody>
                                    </table>
                                    <table class="table table-striped" style="margin-top: -16px;">
                                          <thead>
                                            <tr>
                                              <th scope="col" width="20%" style="background-color: #f5f5f5;"> </th>
                                              <th scope="col" width="80%">Weak risk factors</th>
                                            </tr>
                                          </thead>
                                          <tbody>
                                            <tr>
                                              <th scope="row" style="border-top: none;"></th>
                                              <td>
                                                   <p class="mb-1"><strong>Long-distance travel</strong></p>
                                                   <p class="mb-1"><strong>Smoking</strong></p>
                                              </td>
                                            </tr>
                                          </tbody>
                                    </table>
                                    <table class="table table-striped" style="margin-top: -16px;">
                                          <thead>
                                            <tr>
                                                <th scope="col" width="20%">Drug history</th>
                                                <th scope="col" width="80%">Weak risk factors</th>
                                            </tr>
                                          </thead>
                                          <tbody>
                                            <tr>
                                              <th scope="row" style="border-top: none;"></th>
                                              <td>
                                                   <p><strong>Combined oral contraceptive pill </strong></p>
                                                   <ul>
                                                   <li>The risk of venous thromboembolism (VTE) associated with different combined oral contraceptives (COCs) is influenced by the progestogen type. COCs containing levonorgestrel, norethisterone, or norgestimate have the lowest risk (5-7 events per 10,000 women per year), whereas those containing drospirenone, desogestrel, or gestodene have the highest risk (9-12 events per 10,000 women per year). [EMA]</li>
                                                   <li>Progestogen-only methods of contraception do not appear to be associated with an increased risk of VTE. [FAMP]</li>
                                                   </ul>
                                                   <p><strong>Hormone replacement therapy [NICE]</strong></p>
                                                   <ul>
                                                   <li>There is a small increased risk of PE or DVT associated with use of oral hormone replacement therapy (HRT) but no increased risk from transdermal HRT at standard doses. [NG23]</li>
                                                   </ul>
                                              </td>
                                            </tr>
                                          </tbody>
                                    </table>
                                    <table class="table table-striped" style="margin-top: -16px;">
                                          <thead>
                                            <tr>
                                                <th scope="col" width="20%">Family history</th>
                                                <th scope="col" width="80%">Weak risk factors</th>
                                            </tr>
                                          </thead>
                                          <tbody>
                                            <tr>
                                              <th scope="row" style="border-top: none;"></th>
                                              <td>
                                                   <p><strong>First-degree relative with a history of confirmed PE or DVT. [NICE]</strong></p>
                                              </td>
                                            </tr>
                                          </tbody>
                                    </table>

                                    <div class="evidence-accordion">
                                          <div class="option">
                                          <input type="checkbox" id="toggle1" class="toggle" />
                                          <label class="title" for="toggle1">Evidence: Cancer as a risk factor</label>
                                          <div class="content">
                                                <p><strong><em>significantly increases the risk of a PE</em></strong></p>
                                                <p><strong>Evidence suggests that the overall risk of venous thromboembolism (VTE) in cancer patients is four times higher than in the general population.</strong> [HEIT] </p>
                                                <ul>
                                                <li>Although the largest absolute number of VTE episodes occur in patients with lung, colon, and prostate cancer, a population-based cohort study demonstrated that the relative risk for VTE was highest in multiple myeloma, brain, and pancreatic cancer (46-, 20- and 16fold increased risk vs. healthy controls respectively). [FREYZEK]</li>
                                                <li>In the metastatic stage, there is evidence that stomach, bladder, uterine, renal, and lung cancer are also associated with a high incidence of VTE. [HARVEY]</li>
                                                </ul>
                                          </div>
                                          </div>
                                          </div>


                              </div>



                           </div>
                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                              <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-234234">
                                 <h3>Physical examination</h3>
                              </div>
                           </div>
                           <div id="collapseTest-18f09885-71b3-436a-b52e-234234" class="row rowDetails p-3 collapse">
                              <p><strong>Physical examination is often non-specific unless a PE is massive/central. However, on examination you should check for:</strong></p>
                                 <ul>
                                 <li><strong>Signs of a concurrent DVT.</strong> Examine the lower limbs for tenderness, changes to skin colour and temperature, and venous distension. [NICEDVT]</li>
                                 <li><strong>Hypoxaemia</strong>.  This may be present only on exertion in smaller PEs but the patient may appear tachypnoeic. [NICE]</li>
                                 <li><strong>Crepitations</strong> on auscultation of the lungs [NICECKS]</li>
                                 <li><strong>Fever. </strong>Temperature &gt;37.8&deg;C. [BELL]</li>
                                 </ul>

                                 <div id="tip_pitfall" class="card card-inverse mb-4">
                                 <div class="card-block">
                                 <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                 <p class="card-text"><strong>It is possible for PE and pneumonia to co-exist.</strong></p>
                                 <ul>
                                 <li>Fever may be present in both but tends to be higher(>39°C) in pneumonia. [STEIN PD]
                                    </li>
                                 </ul>
                                 <p class="card-text"><strong>It is important to note that chest pain on palpation of the chest wall occurs in up to 20% of people with PE. </strong></p>
                                 <ul>
                                 <li>Therefore do not use this finding to distinguish musculoskeletal chest pain from PE. [CP]
                                    </li>
                                 </ul>
                                 </div>
                                 </div>
                              
                              <p><strong>Look for features of a massive/central PE and/or severely reduced haemodynamic reserve including:</strong></p>
                                 <ul>
                                 <li><strong>Shock or hypotension (systolic BP &lt;90 mmHg).</strong></li>
                                 <li>Present in less than 5% of patients with acute PE. [LAPORTE]</li>
                                 <li>Look for signs of altered cognition. Agitation and distress characterise early and milder stages, whereas unresponsiveness indicates more severe and advanced shock.</li>
                                 <li>Check for cool extremities, clamminess, mottled or ashen skin, slow capillary refill, and oliguria.</li>
                                 <li>Tachycardia (heart rate &gt;100 bpm)</strong> is an important sign of a possible high-risk PE even in the absence of other signs of shock.</li>
                                 <li><strong>Signs of acute  right ventricular (RV) strain. </strong>The patient may have an elevated jugular venous pressure, sternal heave or accentuated pulmonary component of S2, although this is uncommon. [JC]</li>
                                 </ul>
                                       
                           </div>
                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                              <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-asda345">
                                 <h3>Assessing the clinical probability of PE</h3>
                              </div>
                           </div>
                           <div id="collapseTest-18f09885-71b3-436a-b52e-asda345" class="row rowDetails p-3 collapse">
                              <p><strong>The symptoms and signs of PE are non-specific and no individual risk factor, patient symptom, or clinical sign can definitively diagnose or exclude PE. [ESC]</strong></p>
                                 <ul>
                                 <li>Assessment of clinical probability is therefore a key step in the diagnostic approach.</li>
                                 </ul>
                                 <p><strong>PE can be ruled out in around 30% of patients who present to the emergency department with a suspected PE through a combination of clinical probability assessment using the Wells (or Geneva) score, plus D-dimer testing if indicated.</strong> [ESC]</p>
                                 <ul>
                                 <li>This probability-based approach <strong>minimises the unnecessary use of potentially harmful computed tomographic pulmonary angiography (CTPA)</strong> in patients who have a low probability of a PE. [ARN]</li>
                                 <li><strong>Haemodynamically stable patients</strong> are categorised as '<strong>PE likely</strong>' or '<strong>PE unlikely</strong>' based on their Wells (or Geneva) score.</li>
                                 <li><strong>Start anticoagulation and arrange CTPA for any patient in the 'PE likely' group</strong></li>
                                 <li>The use of the <strong>Pulmonary Embolism Rule-Out Criteria (PERC) </strong>is becoming increasingly widespread to further assess patients categorised as '<strong>PE unlikely</strong>' based on Wells (or Geneva) score.
                                 <ul>
                                 <li>A PE can effectively be ruled out in any such patient who meets all the PERC criteria. [ACP]</li>
                                 <li>Those who do not meet the PERC criteria should have a <strong>D-dimer test.</strong></li>
                                 </ul>
                                 </li>
                                 </ul>

                                 <h3>Wells score</h3>
                                 <p><strong>If a non-pregnant patient with suspected PE is haemodynamically stable, use the Wells (or Geneva) score to assess the clinical probability of PE and to guide investigations. [ESC]</strong></p>
                                 <p><strong>The two-level Wells score categorises patients as ‘PE likely’ (Wells score >4) or ‘PE unlikely’ (Wells score ≤4).</strong>[ESC][NICE]</p>
                                 <ul><li>A simplified version is also available, under which each criterion scores a single point. A total score of 0-1 is categorised as ‘PE unlikely’ and a score of ≥2 is categorised as ‘PE likely’.</li>
                                 <li>An earlier three-level iteration of the Wells score (where patients are categorised into low, moderate, or high clinical probabilities of PE) has been used but the two-level score is generally preferred. [ESC] 
                                 </li></ul>
                                 <div class="table-responsive">
                                    <table class="alt-table">
                                       <thead>
                                          <th scope="col">Criterion</th>
                                          <th scope="col">Wells score points</th>
                                       </thead>
                                       <tbody>
                                          <tr>
                                             <td>Clinical signs of DVT (minimum of leg swelling and pain with palpation of deep veins)</td>
                                             <td>3</td>
                                          </tr>
                                          <tr>
                                             <td>Alternative diagnosis is less likely than PE</td>
                                             <td>3</td>
                                          </tr>
                                          <tr>
                                             <td>Previous PE or DVT</td>
                                             <td>1.5</td>
                                          </tr>
                                             <tr>
                                                <td>Heart rate >100 bpm</td>
                                                <td>1.5</td>
                                             </tr>
                                             <tr>
                                                <td>Surgery (last 4 weeks) or immobilisation for >3 days</td>
                                                <td>1.5</td>
                                             </tr>
                                             <tr>
                                                <td>Haemoptysis</td>
                                                <td>1</td>
                                             </tr>
                                             <tr>
                                                <td>Active cancer</td>
                                                <td>1</td>
                                             </tr>
                                       </tbody>
                                    </table>
                                 </div>

                                 <div id="tip_pitfall" class="card card-inverse mb-4">
                                    <div class="card-block">
                                    <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                    <p class="card-text"><strong>Wells score is commonly used in the UK but an alternative  called the Geneva score is also available. </strong></p>
                                    <ul>
                                    <li>Choose which score to use based on  local protocols.</li>
                                    </ul>
                                    <p class="card-text"><strong>Do not use Wells or Geneva scores in pregnancy.</strong></p>
                                    <ul>
                                    <li>If you suspect PE in a pregnant patient, seek advice from a senior clinician.</li>
                                    </ul>
                                    </div>
                                    </div>
                                       
                                 <p><strong><u>PE likely</u> (Wells score&gt;4)</strong></p>
                                    <p><strong>Give immediate anticoagulation to any patient with a Wells Score &gt; 4 (unless contraindicated) while awaiting investigation with definitive imaging (CTPA if available).</strong> [ESC]</p>
                                    <ul>
                                    <li><strong>If anticoagulation is contraindicated these patients will require close monitoring</strong> to observe for signs of cardiorespiratory deterioration. <strong>Prioritise these patients for urgent investigation </strong>which may include an urgent echocardiography to assess RV function as well as CTPA to confirm or exclude a PE.</li>
                                    </ul>
                                    <p><strong>Do not perform D-dimer testing if a patient&rsquo;s Wells score puts them in the 'PE likely' category</strong> as imaging is warranted regardless of a negative D-dimer value. [ESC] [ACP]</p>
                                    <p><strong><u>PE unlikely</u> (Wells score &le;4)</strong></p>
                                    <p><strong>If a patient has a Wells score &le;4 ('PE unlikely'), apply the Pulmonary Embolism Rule-Out Criteria (PERC) to determine whether or not further investigations are needed. </strong>[ACP]</p>

                                 <div class="evidence-accordion">
                                       <div class="option">
                                          <input type="checkbox" id="toggle2" class="toggle" />
                                          <label class="title" for="toggle2">Evidence: Wells vs Geneva scores</label>
                                          <div class="content">
                                             <p><strong>Wells and Geneva scores have similar sensitivity and specificity</strong></p>   
                                             <p><strong>In a systematic review PE was confirmed in 12% of patients classified as 'PE unlikely' and in 50% of patients classified as 'PE likely'.</strong> [CER].</p>
                                                <ul>
                                                   <li>Neither one of Wells or Geneva score has been shown to be superior to the other. However, the Geneva score is based solely on objective clinical terms and may be more reproducible whereas Wells includes a subjective judgement of whether an alternative diagnosis is less likely than PE. [ESC]</li>
                                                   <li>Sensitivity of the Wells and Geneva scores ranged from 88% to 96% and specificity from 48% to 53% when each clinical decision tool was validated in a primary care dataset. [HEN] </li>
                                                </ul>
                                          </div>
                                       </div>
                                 </div>

                                    <h3>Pulmonary Embolism Rule-Out Criteria (PERC)</h3>
                                       <p><strong>Apply PERC to any patient in whom a PE was initially suspected but who is classified as 'PE unlikely'</strong><strong>using Wells (or Geneva) score</strong>. </p>
                                       <ul>
                                       <li><strong>No further investigation is indicated if a patient meets all the PERC criteria (a PE can effectively be ruled out). </strong>The risk for PE is considered to be lower than the risk of testing. [RAJA] [ACP]</li>
                                       <li><strong>Request D-dimer testing for any patient in whom the PERC criteria fail to rule out a PE (i.e., one of more criterion not fulfilled).</strong></li>
                                       <li>The PERC criteria are:
                                       <ul>
                                       <li>Age &lt;50 years</li>
                                       <li>Heart rate &lt;100 bpm</li>
                                       <li>SaO₂ on room air &ge;95%</li>
                                       <li>No unilateral leg swelling</li>
                                       <li>No haemoptysis</li>
                                       <li>No recent surgery or trauma (&le;4 weeks ago requiring treatment with general anaesthesia)</li>
                                       <li>No prior PE or DVT</li>
                                       <li>No hormone use (oral contraceptives, hormone replacement, or oestrogenic hormones used in male or female patients)</li>
                                       </ul>
                                       </li>
                                       </ul>

                                    <div class="evidence-accordion">
                                       <div class="option">
                                       <input type="checkbox" id="toggle3" class="toggle" />
                                       <label class="title" for="toggle3">Evidence: PERC</label>
                                       <div class="content">
                                          <p><strong><em>Use of PERC can help prevent over-investigation</em></strong></p>
                                             <p><strong>A large meta-analysis of 12 studies determined that the overall proportion of PEs missed by using PERC was only 0.3% (44 of 14,844 total cases).</strong></p>
                                             <ul>
                                             <li>The pooled sensitivity of PERC across all 12 studies was 97% (95% CI, 96% to 98%), and the pooled specificity was 22% (95% CI, 22% to 23%), indicating that 22% of D-dimer tests could have been safely avoided had the PERC approach been universally applied. [SINGH]</li>
                                             </ul>
                                       </div>
                                       </div>
                                       </div>

                           </div>
                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                              <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-hjkhjk">
                                 <h3>Investigations</h3>
                              </div>
                           </div>
                           <div id="collapseTest-18f09885-71b3-436a-b52e-hjkhjk" class="row rowDetails p-3 collapse">
                              <h3><strong>Laboratory tests</strong></h3>
                                 <p><strong>D-dimer</strong></p>
                                 <ul>
                                 <li><strong>Request D-dimer testing in any patient whose Wells (or Geneva) score categorises them as &lsquo;PE unlikely&rsquo; but who fails to fulfil all the PERC criteria.</strong> [RAJA] [ACP]</li>
                                 <li><strong>Do not use D-dimer testing in patients </strong><strong>whose Wells (or Geneva) score categorises them as &lsquo;PE likely&rsquo; </strong>as a negative result will not remove the need for further imaging. [RAJA] [ACP]</li>
                                 <li><strong>A normal plasma D-dimer level (typically &lt;500 nanograms/mL, but check the local threshold) safely excludes PE</strong> in patients with an unlikely pre-test probability of PE and no further investigation is required. [ACP][ESC][NICE][RAJA] The <strong>risk of PE within 3 months is &lt;1%</strong> in these patients. [CARRIER]</li>
                                 <li><strong>If a patient has a raised D-dimer level, start anticoagulation (unless contraindicated) and arrange CTPA to confirm or exclude PE (unless a concurrent DVT is suspected)</strong>. [NICE] [ESC] [ACP]</li>
                                 </ul>
                                 <p><strong>D-dimer testing is highly sensitive (&gt;95%)</strong> in patients in whom pre-test probability suggests that PE is unlikely. [RAJA] However, its specificity is low and may decline with increasing patient age. [RAJA]</p>

                                 <div id="tip_pitfall" class="card card-inverse mb-4">
                                    <div class="card-block">
                                    <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                    <p class="card-text"><strong>Remember that a D-dimer level is a continuous variable. </strong></p>                                 <ul>
                                    <li>A low D-dimer does not mean no risk of PE and a slightly higher D-dimer does not mean a step increase in PE risk.</li>
                                    <li>The threshold value (check what value is used by your local laboratory) is the optimum for balancing sensitivity and specificity.</li>
                                    </ul>
                                    <p class="card-text"><strong> In practice, many people have a raised D-dimer without having a PE.</strong></p>                        <ul>
                                          <li>It is more frequently elevated in patients with cancer, in hospitalised patients, with increasing age, with acute inflammatory conditions and infection, and during pregnancy. Take this into consideration if investigating these patient groups. [ESC] [NICE]
                                          </li>
                                       </ul>
                                    </div>
                                 </div>
                                 
                                    <p><strong><u>Full blood count</u></strong></p>
                                    <ul>
                                    <li><strong>May indicate thrombocytopenia or anaemia.</strong> These patients are at an increased risk of complications from bleeding when taking an anticoagulant.</li>
                                    <li>Heparin therapy can be associated with <strong>heparin-induced thrombocytopenia;</strong> Measure platelet count at baseline and regularly throughout treatment.</li>
                                    <li>May also indicate <strong>thrombocythaemia </strong>or <strong>polycythaemia, </strong>which increase the risk of venous thromboembolism (VTE).</li>
                                    </ul>
                                    <p><strong><u>Urea and electrolytes</u></strong></p>
                                    <ul>
                                    <li><strong>Check baseline renal function</strong>. Doses of some anticoagulants (e.g., low molecular weight heparin, fondaparinux, apixaban, rivaroxaban, dabigatran, edoxaban) may need to be adjusted in patients with renal impairment. [NICE]</li>
                                    <li>Renal function results<strong> can also be used to guide investigations.</strong> For example using CTPA in patients with severe renal impairment can risk contrast-induced nephropathy.</li>
                                    </ul>
                                    <p><strong><u>Coagulation studies</u></strong></p>
                                    <ul>
                                    <li><strong>Order international normalised ratio (INR), prothrombin time (PT), and activated partial thromboplastin time (aPTT)</strong>. These are needed to establish baseline values before starting anticoagulation.</li>
                                    <li>Also aids decisions about the safety and choice of initial anticoagulation. [NICE]</li>
                                    </ul>
                                    <p><strong><u>Liver function tests</u></strong></p>
                                    <ul>
                                    <li>Abnormal LFTs can influence the choice of anticoagulation.</li>
                                    </ul>
                                    <p><strong><u>Arterial blood gas (ABG)</u></strong></p>
                                    <ul>
                                    <li><strong>Do not perform an ABG if the oxygen saturations are within normal range on room air.</strong></li>
                                    <li><strong>Consider ABG in patients who have low oxygen saturations. </strong>However, be aware that it is of very limited diagnostic utility, either alone or in combination with other clinical variables, in suspected PE.[ROGER]</li>
                                    </ul>
                                    <p></p>

                                 <div class="evidence-accordion">
                                    <div class="option">
                                    <input type="checkbox" id="toggle4" class="toggle" />
                                    <label class="title" for="toggle4">Evidence: Role of ABG</label>
                                    <div class="content">
                                    <p><strong>ABG has a limited role in diagnosing PE</strong></p>
                                       <ul>
                                       <li>A PaO₂ &lt;80 mmHg (10.7 kPa), a PaCO₂ &lt;36 mmHg (4.6 kPa), or an abnormal alveolar-arterial gradient (A&ndash;aO₂) are not predictive of PE in patients suspected of having PE. [ROGER]</li>
                                       <li>In patients with suspected acute PE with normal arterial blood gas (ABG) results, PE could not be excluded in 38% of those without cardiopulmonary disease or in 14% of those who had pre-existing cardiopulmonary disease. [PD]</li>
                                    </ul>
                                    </div>
                                    </div>
                                    </div>

                                    <p><strong><u>Cardiac biomarkers</u></strong></p>
                                    <p><strong>The cardiac biomarkers high sensitivity troponin (either I or T), NT-proBNP or BNP are not used in diagnosing PE.</strong> [BTS]</p>
                                    <ul>
                                    <li>They can be used in combination with risk stratification scoring (the full Pulmonary Embolism Severity Index score [PESI], or its simplified sPESI version) to aid <strong>prognostic assessment of patients with confirmed or highly suspected PE, particularly to guide decisions about early discharge for low-risk patients</strong>. [ESC]</li>
                                    </ul>

                                    <p><strong>Measure a cardiac biomarker in a patient with a confirmed or highly suspected PE (positive D-dimer or Wells score &gt;4) only if all three of the following criteria are met: [BTS]</strong></p>
                                    <ul>
                                    <li>Risk stratification puts the patient in the low-risk group (PESI I-II or sPESI 0), AND</li>
                                    <li>Incidental RV strain was identified on CTPA or echocardiography performed as part of the diagnostic work-up, AND</li>
                                    <li>The patient is considered potentially suitable for outpatient management. [BTS]
                                    <ul>
                                    <li>If the cardiac biomarker is normal, you can consider the patient for discharge (after appropriate discussion with a senior). [BTS]</li>
                                    <li>If cardiac biomarker is elevated, admit the patient for observation. [BTS]</li>
                                    </ul>
                                    </li>
                                    </ul>
                                    <p><strong>Do not use routinely to risk stratify patients</strong></p>
                                    <p><strong>Seek senior review if there is an incidental finding of an elevated troponin in a patient with a low-risk PE (PESI I or II/sPESI 0)</strong></p>
                                    <ul>
                                    <li>An alternative cause for elevated troponin should be considered. [BTS]</li>
                                    </ul>

                                    <p><em>For more detail on risk stratification, see the <a href="116_management_recommendations.html" title="management recommendations">Management - Recommendations</a> section.</em></p>

                                    <div class="evidence-accordion">
                                          <div class="option">
                                          <input type="checkbox" id="toggle5" class="toggle" />
                                          <label class="title" for="toggle5">Evidence: Cardiac biomarkers</label>
                                          <div class="content">
                                          <p><strong>Elevated cardiac biomarkers predict a worse outcome</strong></p>
                                          <p><strong>Elevated plasma troponin levels on admission have been reported to be associated with a worse prognosis.</strong></p> 
                                             <ul>
                                             <li>A meta-analysis covering a total of 1985 patients showed elevated cardiac troponin I or T concentrations in approximately 50% of the patients with acute PE. Elevated troponin concentrations were associated with higher mortality both in unselected patients and haemodynamically stable patients. [BECATTINI]
                                                </li>
                                             </ul>
                                             <p><strong>Low levels of BNP or NT-proBNP can identify patients with a favourable short-term outcome based on their high negative predictive value.</strong> [COUTANCE]</p>
                                             <ul>
                                             <li>The plasma levels of BNP and NT-proBNP reflect the severity of haemodynamic compromise and (presumed) RV dysfunction in acute PE. RV pressure overload is associated with increased myocardial stretch, which leads to the release of BNP or NT-proBNP and therefore raised plasma levels. [ESC]</li>
                                             <li>A meta-analysis found that 51% of 1132 unselected patients with acute PE had elevated BNP or NT-proBNP concentrations on admission. These patients had a 10% risk of early death and a 23% risk of an adverse outcome.[HENZLER]</li>
                                          </ul>
                                          </div>
                                          </div>
                                    </div>

                                          <h3><strong>Imaging</strong></h3>
                                          <p><strong><u>Chest x-ray (CXR)</u></strong></p>
                                            
                                          <p><strong> A CXR is not diagnostic of PE but may be useful to support the diagnosis and is important to rule out other causes.</strong></p>
                                          <ul>
                                             <li>It is <strong>usually normal</strong> in a patient with a PE but an <strong>abnormal CXR does not rule out PE.</strong></li>
                                             <li>In a patient with PE, it may show: [NICE]          
                                             <ul>
                                                <li>Atelectasis</li>
                                                <li>Pleural effusion</li>
                                                <li>Elevation of a</li>
                                                <li>hemidiaphragm</li>
                                             </ul>
                                             </li>
                                          </ul>

                                          <div id="tip_pitfall" class="card card-inverse mb-4">
                                             <div class="card-block">
                                             <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                             <p class="card-text"><strong>Pulmonary infarction secondary to PE can be difficult to distinguish from pneumonia on CXR.</strong></p>
                                             </div>
                                          </div>
                                          
                                          <p><strong><u>ECG</u></strong></p>
                                          <p><strong>An ECG is not diagnostic of PE but can be useful to support the diagnosis of PE or rule out other causes.</strong></p>
                                          <ul>
                                             <li>A normal ECG does not rule out a PE. [NICE]</li>
                                          </ul>
                                          <p><strong>ECG signs that may be present in a patient with PE include:</strong>[ESC][ACP] [DIGBY] [BAJAJ]</p>
                                          <ul>
                                             <li>Normal sinus rhythm</li>
                                             <li>Sinus tachycardia</li>
                                             <li>New right bundle branch block (complete or incomplete)</li>
                                             <li>QR pattern in V1</li>
                                             <li>S1Q3T3 pattern</li>
                                             <li>T wave inversion in V1-V4</li>
                                             <li>ST segment migration in V1 through V4</li>
                                             <li>Atrial arrhythmias, most frequently atrial fibrillation</li>
                                             <li>Non-specific ST-segment and T-wave abnormalities</li>
                                             <li>Right axis deviation</li>
                                             <li>P-pulmonale</li>
                                             </ul>

                                             <div class="evidence-accordion">
                                                <div class="option">
                                                <input type="checkbox" id="toggle6" class="toggle" />
                                                <label class="title" for="toggle6">Evidence: ECG</label>
                                                <div class="content">
                                                <p><strong>Some ECG signs are predictors of a poor outcome</strong></p>
                                                   <ul>
                                                   <li>A systematic review and meta-analysis looked at the value of using ECG in predicting clinical deterioration and mortality in acute PE.</li>
                                                   <li>It found that ECG signs that were good predictors of a poor outcome included S1Q3T3, complete right bundle branch block, T-wave inversion, right axis deviation, and atrial fibrillation. [DIGBY]</li>
                                                   </ul>
                                                </div>
                                                </div>
                                             </div>

                                          <p><strong><u>Computed tomographic pulmonary angiography (CTPA)</u></strong></p>
                                          <ul>
                                          <li><strong>CTPA is the preferred investigation for definitive confirmation of PE</strong><ul>
                                          <li><strong>Diagnosis is confirmed by direct visualisation of a thrombus in a pulmonary artery, </strong>which appears as a partial or complete intraluminal filling defect.</li>
                                          </ul></li>                                          
                                          <li><strong>CTPA is indicated in:</strong>
                                          <ul>
                                          <li><strong>Patients with suspected PE who are haemodynamically unstable at presentation </strong>(provided CTPA is immediately available and the patient is well enough to have it - in practice this is often not the case and echocardiography is used instead).</li>
                                          <li><strong>Patients who are classified as &lsquo;PE likely&rsquo; based on Wells (or Geneva) score.</strong></li>
                                          <li><strong>Patients who are classified as &lsquo;PE unlikely&rsquo; based on Wells or Geneva score but who have a positive D-dimer test. </strong>[NICE]</li>
                                          </ul></li>
                                          <li><strong>Avoid CTPA if possible in pregnant women and younger patients</strong>, especially if PE can be ruled out by other non-invasive methods with less radiation exposure. [ARN]</li>
                                          <li><strong>PE does not need to be confirmed on CTPA prior to discharge in low-risk patients (PESI I-II or sPESI 0) who are suitable for outpatient management but it should be performed within 24 hours </strong>(if available). [BTS]</li>
                                          </ul>
                                          
                                          <div class="evidence-accordion">
                                             <div class="option">
                                             <input type="checkbox" id="toggle7" class="toggle" />
                                             <label class="title" for="toggle7">Evidence: CTPA risks</label>
                                             <div class="content">
                                                <p><strong><em>CTPA must be used judiciously to ensure benefits outweigh risks</em></strong></p>
                                                <p><strong>Radiation from CT is considered to be a risk factor for cancer.</strong></p>
                                                <ul>
                                                <li>In one study, a cohort of children with CT exposure was found to have a significantly higher incidence of leukaemia and brain tumours later in life. Women in particular are also at significant risk due to the imaging of radiosensitive breast tissue during CTPA. [ACP]</li>
                                                </ul>
                                                <p><strong>The contrast dye used in CTPA for the evaluation of PE may cause nephropathy.</strong></p>
                                                <ul>
                                                <li>In a prospective study, 174 patients underwent CTPA, which demonstrated acute PE in 7%. Some 12% developed contrast-induced nephropathy including one patient with acute PE. Development of contrast-induced nephropathy was associated with an increased risk of severe renal failure and death within the subsequent 45 days.</li>
                                                </ul>
                                                <p><strong>Repeated imaging is common, which may magnify these risks.</strong></p>
                                                <ul>
                                                <li>In one study performed at a large academic centre, at least one third of emergency department patients who had CTPA for the evaluation of PE underwent another CT for the same reason within 5 years. [KLINE]</li>
                                                </ul>
                                                <p><strong>More widespread use of CTPA may lead to overdiagnosis of subsegmental PEs that are often of little clinical significance. </strong></p>
                                                <ul>
                                                <li>The diagnostic value and clinical significance of subsegmental defects identified on CTPA remains hotly debated. [ESC take-home messages doc].</li>
                                                <li>Evidence suggests that there has been minimal or no associated change in patient outcomes despite the increased use of CTPA. It is thought that this is due to increased identification of less severe PEs (such as subsegmental PEs) that would not have previously been diagnosed and that may not be clinically relevant. [BOONE] [BRODER] [SOJ]</li>
                                                <li>There is a lack of evidence to support decisions on whether or not to treat patients who have incidental PE detected by CTPA, although they probably should be treated if they have cancer and a proximal clot. [TH]</li>
                                                <li>Potentially inappropriate overuse of CTPA results in increased risks to patients as well as higher costs.[ACP]</li>
                                                </ul>
                                             </div>
                                             </div>
                                          </div>
                                          
                                          <div class="evidence-accordion">
                                             <div class="option">
                                             <input type="checkbox" id="toggle8" class="toggle" />
                                             <label class="title" for="toggle8">Evidence: CTPA predictive value</label>
                                             <div class="content">
                                                <p><strong><em>The predictive value of CTPA depends on the pre-test probability of PE</em></strong></p>
                                                <p><strong>The PIOPED II trial highlighted the influence of clinical probability on the predictive value of CTPA.</strong> [PIOPED]</p>
                                                <ul>
                                                <li>The negative predictive value for PE of a negative CTPA was dependent on pre-test clinical probability of PE as assessed by the Wells score (96% for those with a low probability pre-test Wells score and 89% for those with an intermediate probability score, but only 60% for those with a high probability Wells score - based on the three-level Wells Score)</li>
                                                <li>Conversely the positive predictive value of a positive CTPA was high (92%-96%) in patients with an intermediate or high probability pre-test Wells score but only 58% in those with a low probability pre-test score.</li>
                                                </ul>
                                                <p><strong>Therefore, clinicians should be particularly cautious in case of discrepancy between clinical judgement and the CTPA result.</strong> However a normal CTPA excludes a PE in a patient whose pre-test Wells (or Geneva) score categorised them as PE unlikely. [ESC]</p>
                                             </div>
                                             </div>
                                          </div>
                                          
                                          <p><strong><u>Echocardiography</u></strong></p>
                                          <ul>
                                          <li><strong>Use echocardiography as an alternative diagnostic investigation for haemodynamically unstable patients with suspected PE who cannot have CTPA</strong>.
                                          <ul>
                                          <li>If CTPA is not immediately available or the patient is too unwell to be moved, perform a bedside echocardiography.</li>
                                          <li><strong>The presence of any signs of RV dysfunction is sufficiently strongly suggestive of PE to justify emergency reperfusion </strong>treatment (usually thrombolysis). [ESC]</li>
                                          </ul></li>
                                          <li><strong>Echocardiography can also identify important alternative causes of shock</strong>, such as pericardial tamponade, acute valvular dysfunction, severe global or regional LV dysfunction, aortic dissection, or hypovolaemia.</li>
                                          <li><strong>Do not use echocardiography routinely in haemodynamically stable patients with suspected PE. </strong></li>
                                          <li><strong>Findings in PE include: [ESC]</strong>
                                          <ul>
                                          <li>Abnormal RV ejection pattern (so-called<strong> &lsquo;60&ndash;60 sign&rsquo;</strong>)</li>
                                          <li>Reduced contractility of the RV free wall compared with the RV apex <strong>(&lsquo;McConnell sign&rsquo;</strong>)[ESC]</li>
                                          <li>RV dilatation and hypokinesis</li>
                                          <li>RV diameter/LV diameter &gt;0.9</li>
                                          <li>Interventricular septal flattening and paradoxical leftward septal motion</li>
                                          <li>Presence of tricuspid regurgitation</li>
                                          <li>Presence of pulmonary hypertension (peak tricuspid jet velocity &gt;2.6 m/s and loss of respirophasic IVC collapse)</li>
                                          </ul></li>
                                          <li><strong>Mobile right heart thrombi</strong> can be detected by transthoracic or transoesophageal echocardiography (or by CT angiography) in less than 4% of unselected patients with PE. This finding essentially confirms the diagnosis of PE and is <strong>associated with RV dysfunction and high early mortality</strong>. [ESC]</li>
                                          </ul>

                                          

                                          <div id="tip_pitfall" class="card card-inverse mb-4">
                                             <div class="card-block">
                                             <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                             <p class="card-text">
                                                <p><strong>A negative echocardiography does not exclude PE. [ESC]</strong></p>
                                             <ul>
                                             <li>The reported negative predictive value for PE is 40% to 50%.</li>
                                             </ul>
                                             <p><strong>Assessment of RV function on echocardiography is not obligatory for the identification of low-risk patients who are suitable for outpatient management.</strong> [BTS]</p>
                                             <ul>
                                             <ul>
                                             <li>However, if it has been performed as part of the diagnostic work-up for PE and shows evidence of RV dysfunction, consider measuring a cardiac biomarker to further risk stratify the patient.</li>
                                             </ul>
                                             </ul>
                                             </div>
                                          </div>

                                          <p><strong><u>Lower limb compression venous ultrasound</u></strong></p>
                                          <ul>
                                          <li><strong>Use lower limb compression venous ultrasound to</strong><strong>investigate patients suspected of having a concurrent DVT.</strong>
                                          <ul>
                                          <li>Finding a proximal DVT in patients suspected of having PE is considered sufficient to start anticoagulant treatment without further investigation. [ESC]</li>
                                          </ul></li>
                                          </ul> 

                                          
                                          <div class="evidence-accordion">
                                                <div class="option">
                                                <input type="checkbox" id="toggle9" class="toggle" />
                                                <label class="title" for="toggle9">Evidence: Ultrasound</label>
                                                <div class="content">
                                                      <p><strong><em>Lower limb ultrasound has high sensitivity/specificity for DVT</em></strong></p>
                                                      <ul><li>Lower limb compression venous ultrasound has a sensitivity &gt;90% and a specificity of approximately 95% for symptomatic DVT and shows a DVT in 30% to 50% of patients with PE. [ESC]</li></ul>
                                                </div>
                                                </div>
                                             </div>

                                             <p><strong><u>Ventilation/perfusion (V/Q) scan</u></strong></p>
                                             <ul>
                                             <li><strong>A V/Q scan can be performed in patients with an elevated D-dimer and a contraindication to CTPA</strong> (<strong>such as pregnancy, renal impairment, or contrast allergy)</strong>. [ESC] [ACP] [NICE]</li>
                                             <li><strong>V/Q may be preferred over CTPA in some patient groups to avoid unnecessary radiation</strong>, particularly in younger and female patients in whom CTPA may raise the lifetime risk of cancer. [ESC] [ACP]</li>
                                             </ul>

                                             <div id="tip_pitfall" class="card card-inverse mb-4">
                                                   <div class="card-block">
                                                   <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                                   <p class="card-text"><strong>A V/Q scan is of limited use in patients with significant underlying lung disease, left ventricular failure, or congestive cardiac failure. [ESC]
                                                      </strong></p>
                                                   </div>
                                                </div>

                                                                                         
                                          <div class="evidence-accordion">
                                                <div class="option">
                                                <input type="checkbox" id="toggle10" class="toggle" />
                                                <label class="title" for="toggle10">Evidence: Ruling out PE with a V/Q scan</label>
                                                <div class="content">
                                                   <p><strong><em>Evidence supports the potential use of V/Q scanning as the first-line imaging test for PE in younger patients</em></strong></p>
                                                   <ul>
                                                         <li>V/Q lung scintigraphy has been shown to be diagnostic (with either normal or high-probability findings) in approximately 30% to 50% of emergency ward patients with suspected PE. The proportion of diagnostic V/Q scans was higher in patients with a normal chest x-ray. [DIDIER]</li>
                                                         <li>The number of patients with inconclusive findings on V/Q scan may be reduced by taking into account clinical probability. Evidence shows that patients with a negative lung scan and low clinical probability of PE have a low prevalence of confirmed PE. The negative predictive value of this combination is further increased by the absence of a DVT on lower limb compression venous ultrasound. [PIOPE90][SORSH]</li>
                                                         </ul>
                                                </div>
                                                </div>
                                             </div>


                           </div>
                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                              <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-fhfhfg">
                                 <h3>Suspected PE in pregnancy</h3>
                              </div>
                           </div>
                           <div id="collapseTest-18f09885-71b3-436a-b52e-fhfhfg" class="row rowDetails p-3 collapse">
                     
                           <p><strong>PE is the leading cause of maternal mortality in developed countries</strong>.[ESC] [TOWER]</p>
                           <ul>
                           <li>There is a <strong>fourfold increased risk of VTE</strong> throughout pregnancy compared with non-pregnant women and this is relatively equal across all three trimesters.</li>
                           <li>This risk rises sharply in the postnatal period and is <strong>up to 60 times higher in the 3 months after delivery</strong>, compared with the risk in non-pregnant women.</li>
                           </ul>
                           <p><strong>Symptoms and signs of PE may be less specific in pregnant women</strong>. [ACP]</p>
                           <ul>
                           <li><strong>Be cautious in interpreting breathlessness </strong>as it is a common symptom in pregnancy. [ESC]</li>
                           </ul>
                           <p><strong>If you suspect PE in a pregnant patient, seek advice from a senior clinician.</strong></p>
                           <ul>
                           <li><strong>Do not use the Wells (or Geneva) score </strong>in pregnancy - they are not reliable predictors of the probability of PE.</li>
                           </ul>
                           <p><strong>Minimise exposure to radiation-associated imaging when investigating suspected PE in a pregnant woman. </strong></p>
                           <ul>
                           <li>Use <strong>lower limb compression ultrasound</strong> if concurrent DVT is suspected. Some centres now advocate bilateral lower limb ultrasound even if there are no clinical signs of DVT.</li>
                           <li>There is<strong> debate over whether V/Q scan or CTPA is preferred</strong> for the next step.
                           <ul>
                           <li>The European Society of Cardiology and the American Thoracic Society consensus guidelines recommend a V/Q scan if the patient has had a normal CXR, with a CTPA if the V/Q scan is inconclusive. [LEUNG] [ESC]</li>
                           <li>In practice the decision between perfusion scanning and CTPA will depend on local equipment and expertise, as well as patient factors (normal CXR, ability to hold breath). [ACR]</li>
                           <li>Halve the administered dose of radiopharmaceutical when lung scans are indicated in pregnant women; longer acquisition times should be used to achieve adequate imaging. [STRAITON]</li>
                           </ul></li>
                           </ul>

                                         
                           <div class="evidence-accordion">
                                 <div class="option">
                                 <input type="checkbox" id="toggle11" class="toggle" />
                                 <label class="title" for="toggle11">Evidence: Clinical probability scores in pregnancy</label>
                                 <div class="content">
                                       <p><strong><em>Data is lacking on the validity of clinical probability scores in pregnancy</em></strong></p>
                                       <ul>
                                       <li>A recent retrospective series of 125 pregnant women who were referred for CTPA showed that no patient with an initial Wells score &lt;6 had a PE. [CONNOR]</li>
                                       <li>These results need to be confirmed in large-scale prospective studies. In the meantime these scoring tools should not be used.</li>
                                       </ul>
                                 </div>
                                 </div>
                              </div>

                              <div class="evidence-accordion">
                                    <div class="option">
                                    <input type="checkbox" id="toggle12" class="toggle" />
                                    <label class="title" for="toggle12">Evidence: D-dimer in pregnant women</label>
                                    <div class="content">
                                          <p><strong><em>The use of D-dimer in pregnancy remains controversial</em></strong></p>
                                          <p><strong>A normal D-dimer result has the same exclusion value for PE in pregnant women as for other patients with suspected PE but is found more rarely.</strong></p> 
                                          <ul>
                                                <li>This is because plasma D-dimer levels rise physiologically throughout pregnancy. [CHABLOZ]</li>
                                                <li>A study of a series of pregnant patients with suspected DVT found that an agglutination assay would have ruled out the diagnosis in 55% of the cases with a negative predictive value of 100%. [CHAN]The same study attempted to establish higher cut-off levels in pregnancy for several commonly used D-dimer assays.</li>
                                                <li>These thresholds await prospective validation. In the meantime, check local guidance on whether to use D-dimer in pregnancy and what cut-off value should apply to rule out PE in pregnancy. [ESC]</li>
                                                </ul>
                                    </div>
                                    </div>
                                 </div>


                           </div>

                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                              <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-4j6n7m8">
                                 <h3>Further assessment and investigation of unprovoked PE</h3>
                              </div>
                           </div>
                           <div id="collapseTest-18f09885-71b3-436a-b52e-4j6n7m8" class="row rowDetails p-3 collapse">
                                
                              <p><strong>An unprovoked PE is a PE in a patient who had no pre-existing, transient provoking risk factor in the prior 3 months. </strong>[NICE]</p>
                              <ul>
                              <li><strong>Provoking risk factors include: </strong>surgery; trauma; significant immobility (bedbound, unable to walk unaided, or likely to spend a substantial proportion of the day in bed or in a chair); pregnancy or puerperium; use of oral contraceptive/hormone replacement therapy).</li>
                              </ul>
                              <p><strong>An unprovoked PE may be suggestive of an underlying condition so further investigations are sometimes warranted.</strong></p>

                              <h3><strong>Undiagnosed cancer</strong></h3>

                              <p><strong>Offer any patient diagnosed with an unprovoked PE who is not already known to have cancer the following initial investigations:</strong> [NICE]</p>
                              <ul>
                              <li>A physical examination (guided by the patient&rsquo;s full history)</li>
                              <li>Chest x-ray</li>
                              <li>Blood tests (full blood count, serum calcium, and liver function tests)</li>
                              <li>Urinalysis</li>
                              </ul>
                              <p><strong>Consult local guidelines when deciding whether to undertake additional investigations for cancer. </strong></p>
                              <ul>
                              <li>NICE recommends considering a CT scan of the abdomen and pelvis (and a mammogram for women) in any patient over 40 years with a first unprovoked PE who does not have signs or symptoms of cancer based on initial investigation. [NICE]</li>
                              <li>However, in clinical practice it is common to investigate further only if there are signs or symptoms of cancer in the history or examination or abnormalities picked up on initial investigations. Further investigation with CT scan or mammogram can be considered but the sensitivity is low and many local guidelines do not recommend these tests.</li>
                              </ul>

                                                                       
                              <div class="evidence-accordion">
                                    <div class="option">
                                    <input type="checkbox" id="toggle13" class="toggle" />
                                    <label class="title" for="toggle13">Evidence: Cancer screening</label>
                                    <div class="content">
                                       <p><strong><em>The evidence supporting screening for undiagnosed cancer after unprovoked VTE is inconclusive. </em></strong></p>
                                       <ul>
                                             <li>A screening strategy that was proposed in the SOMIT trial included pelvic and abdominal CT combined with mammography and sputum cytology. This was recommended as the most effective and least harmful approach for patients.</li>
                                             <li>However, no 5-year survival benefit was found when this approach was compared with basic clinical evaluation. [PRINS][DOORMAAL]</li>
                                             </ul>
                                    </div>
                                    </div>
                                 </div>

                                 <h3><strong>Thrombophilia testing</strong>[NICE]</h3>
                                 <p><strong>Consider testing for hereditary thrombophilia in a patient who has had an unprovoked PE and who has a first-degree relative who has had a DVT or PE if it is planned to stop anticoagulation treatment.</strong></p>
                                 <ul>
                                 <li>Do not offer thrombophilia testing to patients who are continuing anticoagulation treatment.</li>
                                 </ul>
                                 <p><strong>Consider testing for antiphospholipid antibodies in patients who have had an unprovoked PE if it is planned to stop anticoagulation treatment.</strong></p>
                                 <p><br /><strong>Do not routinely offer thrombophilia testing to first-degree relatives of people with a history of PE and thrombophilia.</strong></p>

                           </div>
                           <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-123hl">
                              <h3>Emerging/future investigations</h3>
                           </div>
                        </div>
                        <div id="collapseTest-18f09885-71b3-436a-b52e-123hl" class="row rowDetails p-3 collapse">
                              <p><strong>Age-adjusted D-dimer testing</strong></p>
                              <ul>
                              <li>Recent evidence suggests <strong>using age-adjusted cut-offs can improve the performance of D-dimer testing in patients aged over 50 years.</strong> [ACP][ESC][SCHOUTEN]</li>
                              <li>D-dimer specificity is low and may decline with increasing patient age. [RAJA]</li>
                              </ul>

                                                                       
                              <div class="evidence-accordion">
                                    <div class="option">
                                    <input type="checkbox" id="toggle14" class="toggle" />
                                    <label class="title" for="toggle14">Evidence:  Age-adjusted D-dimer</label>
                                    <div class="content">
                                          <p><strong><em>Age-adjusted D-dimer thresholds might increase specificity</em></strong></p>
                                          <ul>
                                          <li>A recent meta-analysis of 13 studies and 12,497 patients without high pre-test clinical probability of PE found that the use of age-adjusted D-dimer cut-offs for patients aged over 50 years (age &times; 10 ng/mL) maintained a sensitivity for PE above 97% while significantly increasing specificity. [SCHOUTEN]</li>
                                          <li>In patients with cancer, using an age-adjusted D-dimer cut-off doubled the proportion of patients in whom PE could be excluded by clinical decision rule and D-dimer, without the need for imaging. [WILTS]</li>
                                          </ul>
                                    </div>
                                    </div>
                                 </div>

                                 <p><strong>Magnetic resonance angiography (MRA)</strong></p>
                                 <ul>
                                 <li><strong>The hypothesis is that a negative MRA combined with the absence of proximal DVT on lower limb compression ultrasound may safely rule out clinically significant PE</strong> [ESC]</li>
                                 <ul>
                                 <li>This is being tested in a multicentre outcome study.</li>
                                 </ul>
                                 </ul>
                                 <p><strong>MRA has shown promise but is not yet ready for clinical practice </strong>due to its low sensitivity, high proportion of inconclusive scans, and low availability in most emergency settings.</p>

                        </div>
                        </div>
                     </div>
                  </div>
            </div>

         </div>







         </div> <!--END POCE -->





         <div class="card-block disclaimer">
            <p><span>Use of this content is subject to our <a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">disclaimer</a> </span></p>
         </div>
      </main>
      <!-- set the messages country code variable from region to be used from i18 plugin. Setting here so it's available in all pages -->
      <script>
         /*<![CDATA[*/
         
         var messagesCountryCode = "en_GB";
         /*]]>*/
           
      </script>
      <aside id="panel-nhs" class="card-block">
         <div id="access" class="col-sm-6">
            <div class="row">
               <div class="col-md-6">
                  <p>Access provided by:</p>
               </div>
               <div class="col-md-6">
                  <img src="../images/bmj-logo.png" alt="BMJ Group (Online access from BMA House)">
               </div>
            </div>
         </div>
      </aside>
      <footer id="footer">
         <div class="container">
            <div class="row">
               <nav class="col-md-9" role="navigation">
                  <div class="row">
                     <dl class="col-md-4" role="menu">
                        <dt>Browse</dt>
                        <dd><a href="https://bestpractice.bmj.com/">Home</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/recent-updates">Recent updates</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/specialties">Specialties</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/calculators">Calculators</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/patient-leaflets">Patient leaflets</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/procedural-videos">Procedural videos</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/evidence">Evidence</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/drugs">Drugs</a></dd>
                     </dl>
                     <!-- logged-in individual or institutional user -->
                     <!-- unknown user -->
                     <!--institutional user not logged in-->
                     <dl class="col-md-4" role="menu">
                        <dt>Services</dt>
                        <dd><a href="https://bestpractice.bmj.com/login">Log in</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/registration">Create an account</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/" target="_blank">About us</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/app/" target="_blank">Mobile app</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></dd>
                        <dd>
                           <a href="https://myaccount.bmj.com/myaccount/registration.html?regService=bestpractice-email-alert&amp;fwdUrl=https://bestpractice.bmj.com">
                           Sign up for email alerts
                           </a>
                        </dd>
                     </dl>
                     <dl class="col-md-4" role="menu">
                        <dt>Legal</dt>
                        <dd><a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">Disclaimer</a></dd>
                        <dd><a href="https://www.bmj.com/company/legal-information/" target="_blank">Terms and conditions</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/" target="_blank">Privacy notice</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">Cookie policy</a></dd>
                     </dl>
                  </div>
                  <!-- row -->
               </nav>
               <div class="col-md-3">
                  <ul>
                     <li><a target="_blank" href="https://www.facebook.com/BMJBestPractice"><img alt="Facebook Logo" title="Facebook" src="../images/facebook-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://twitter.com/BMJBestPractice"><img alt="Twiter Logo" title="Twitter" src="../images/twitter-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.linkedin.com/showcase/15218227/"><img alt="LinkedIn Logo" title="LinkedIn" src="../images/linkedIn_logo_circle.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.youtube.com/channel/UCt72GZ0cPXpk4EzgFhdWYdQ"><img alt="Youtube Logo" title="YouTube" src="../images/youtube-64.png" width="60" height="60"></a></li>
                  </ul>
                  <p class="copyright mt-3"><small>© BMJ Publishing Group 2018</small></p>
                  <p class="issn"><small>ISSN 2515-9615</small></p>
               </div>
            </div>
            <!-- row -->  
         </div>
         <!-- container -->    
      </footer>
      <div class="container modal-registration-form" aria-hidden="true">
         <div id="feedbackContainer" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-header">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Help us improve <abbr>BMJ</abbr> Best Practice</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                        <div class="col-md-12">
                           <p>Please complete all fields.</p>
                        </div>
                     </div>
                  </div>
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <form id="feedbackForm" action="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#" novalidate="novalidate">
                              <div class="row">
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackName">Name</label> 
                                       <input id="feedbackName" class="form-control" name="feedbackName" type="text">
                                    </div>
                                 </div>
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackEmail">Email</label> 
                                       <input id="feedbackEmail" class="form-control" name="feedbackEmail" type="email" value="">
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <h2 id="feedbackPageTitle" class="h3">Page: Pulmonary embolism - Approach | BMJ Best Practice</h2>
                                 </div>
                              </div>
                              <input id="feedbackPage" name="feedbackPage" type="hidden" value="Pulmonary embolism - Approach | BMJ Best Practice">
                              <div class="row">
                                 <div class="col-md-4">
                                    <p>I have some feedback on:</p>
                                    <fieldset class="form-group" role="radiogroup">
                                       <legend>Feedback on: </legend>
                                       <label for="feedOn01"><input id="feedOn01" type="radio" name="feedbackOn" value="This page" checked="checked">&nbsp;This page</label>
                                       <label for="feedOn02"><input id="feedOn02" type="radio" name="feedbackOn" value="This website">&nbsp;The website in general</label>
                                       <label for="feedOn03"><input id="feedOn03" type="radio" name="feedbackOn" value="Something else">&nbsp;Something else</label>
                                    </fieldset>
                                 </div>
                                 <div class="col-md-8">
                                    <div class="form-group floating-label textarea">
                                       <label for="feedbackContent">I have some feedback on:</label>
                                       <textarea id="feedbackContent" name="feedbackContent"></textarea>
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <p>We will respond to all feedback.</p>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <button id="feedbackSubmit" type="submit" class="btn btn-secondary btn-lg">
                                    <span id="spinner2" class="progress-circular-inner progress-circular-left"></span>
                                    <span id="btnText2">Submit Feedback</span>
                                    </button>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-12">
                                    <p>For any urgent enquiries please contact our customer services team who are ready to help with any problems.</p>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-3">
                                    <p><b>Phone:</b> +44 (0) 207 111 1105</p>
                                 </div>
                                 <div class="col-md-3">
                                    <p><b>Email: </b> <a href="mailto:support@bmj.com">support@bmj.com</a></p>
                                 </div>
                              </div>
                           </form>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedbackSuccess" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackConfirmedLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Thank you</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                     </div>
                     <div class="row">
                        <div class="col-md-12">
                           <p>Your feedback has been submitted successfully.</p>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedBackBtn">
            <p role="button"><a href="https://bestpractice.bmj.com/topics/en-gb/116/diagnosis-approach#"><span class="material-icons"></span>&nbsp;FEEDBACK</a></p>
         </div>
      </div>
      <script type="text/javascript" src="../js/common.js"></script>
      <script type="text/javascript" src="../js/main.js"></script>
      <script>
         // Code for the recently viewed topics suggestion, needs to be inlined to use the Java values
         /*<![CDATA[*/       
         function dedupe(array) {
           var seen = {};
           return array.filter(function(item) {
               return seen.hasOwnProperty(item.id) ? false : (seen[item.id] = true);
           });
         }
         function TopicViewed(id, title, lang) {
           this.id = id;
           this.title = title;
           this.lang = lang;
         }
         jQuery(document).ready(function() {
           var topicId = 116;
           var topicLang = "en-gb";
           var topicTitle = "Pulmonary embolism";
           if(topicId){
               
             var topicsViewed = [];
             if (localStorage.getItem("topicsViewed") !== null) {
               topicsViewed = JSON.parse(localStorage.topicsViewed);
             }
               
             topicsViewed.unshift(new TopicViewed(topicId, topicTitle, topicLang));// Add new topics at the beginning
             topicsViewed = dedupe(topicsViewed);// Remove duplicates
             if (topicsViewed.length > 15){// Drop if size is bigger than 15
               topicsViewed = topicsViewed.slice(0,14);  
             }
         
             localStorage.topicsViewed = JSON.stringify(topicsViewed);
           }
          });       
         /*]]>*/
      </script>
      <script type="text/javascript">
         _linkedin_data_partner_id = "103646";
      </script>
      <script type="text/javascript">
         (function()
         {var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);}
         )();
      </script>
      <script type="text/javascript" data-cfasync="false">
         (function(W,i,s,e,P,o,p){W['WisePopsObject']=P;W[P]=W[P]||function()
         { (W[P].q=W[P].q||[]).push(arguments)}
         ,W[P].l=1*new Date();o=i.createElement(s),
         p=i.getElementsByTagName(s)[0];o.async=1;o.src=e;p.parentNode.insertBefore(o,p)
         })(window,document,'script','//loader.wisepops.com/get-loader.js?v=1&site=qudyiEfMBd','wisepops');
         window.WisePopsLoaderCallback = function(wisepops) {
                         wisepops._storage.visits = wisepops._storage.visits.slice(0, 2);
                         wisepops._storage._saveVisits();
                       };
      </script>
      <noscript>
         <img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=103646&fmt=gif" />
      </noscript>
      <!--[if lte IE 7]><script>var isIE7OrOlder = true; </script><![endif]-->   
      <!--[if lte IE 9]><script type="text/javascript" src="/gzip_e7393341757851d76c3264b590cf5143/js/browserupdate.js" ></script>
      <![endif]-->
      <script src="../js/adsct" type="text/javascript"></script><script type="text/javascript" id="createCookie">(function(){var b="bestpractice.bmj.com\/topics\/en-gb\/116\/diagnosis-approach",a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};a("RefTrack",b,2);a("RefTrackGroup","bestpractice.bmj.com",2)})();</script><script type="text/javascript" id="copyText">function getSelectionText(){var a="";window.getSelection?a=window.getSelection().toString():document.selection&&"Control"!=document.selection.type&&(a=document.selection.createRange().text);return a}document.addEventListener("copy",function(a){dataLayer.push({event:"textCopied",clipboardText:getSelectionText(),clipboardLength:getSelectionText().length})});</script>
      <script type="text/javascript" id="facebookPixel">!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version="2.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://connect.facebook.net/en_US/fbevents.js");fbq("init","414393182248444");fbq("track","PageView");</script>
      <noscript><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=414393182248444&amp;ev=PageView&amp;noscript=1"></noscript>
      <button id="scrollTop" class="material-scrolltop" type="button"><span class="material-icons"></span></button><script src="../js/saved_resource" type="text/javascript"></script>
   </body>
</html>